Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25-35)
Male Wistar rats received unilateral intrahippocampal injections of 3 nmol (3.18 μg) aggregated Aβ(25–35), intracerebroventricular bilateral injections of 0.5 μg human recombinant TNFα or both (Aβ(25–35) + TNFα‐treated animals). Seven days after the surgery brain sections were stained with cresyl vi...
Gespeichert in:
Veröffentlicht in: | Journal of neuroscience research 2003-01, Vol.71 (1), p.110-120 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 120 |
---|---|
container_issue | 1 |
container_start_page | 110 |
container_title | Journal of neuroscience research |
container_volume | 71 |
creator | Stepanichev, Mikhail Yu Zdobnova, Irina M. Yakovlev, Alexander A. Onufriev, Mikhail V. Lazareva, Natalia A. Zarubenko, Irina I. Gulyaeva, Natalia V. |
description | Male Wistar rats received unilateral intrahippocampal injections of 3 nmol (3.18 μg) aggregated Aβ(25–35), intracerebroventricular bilateral injections of 0.5 μg human recombinant TNFα or both (Aβ(25–35) + TNFα‐treated animals). Seven days after the surgery brain sections were stained with cresyl violet (Nissl), for fragmented DNA (TUNEL), glial fibrillar acidic protein (GFAP) and isolectin B4‐reactive microglia. In addition, caspase‐3 activity in brain regions was measured fluorometrically. The morphology of the hippocampus after the injection of Aβ(25–35) or both Aβ(25–35) and TNFα (but not TNFα alone) showed cell loss in the CA1 pyramidal cell layer. The extension of neuronal degeneration measured in the CA1 field was significantly larger in Aβ(25–35)‐treated groups compared to the contralateral hemisphere of both vehicle‐treated controls and animals injected with TNFα alone. TNFα augmented the Aβ(25–35)‐induced damage, significantly increasing the extension of degenerating area. Administration of Aβ(25–35) caused reactive gliosis in the ipsilateral hemisphere as demonstrated by upregulation of GFAP expression and the presence of hypertrophic astrocytes in the hippocampus. This effect was much more prominent in the hippocampi of rats treated with Aβ(25–35) + TNFα but absent after administration of TNFα alone. In both Aβ(25–35)‐treated groups, the damaged area of the hippocampal CA1 field and lateral band of dentate gyrus displayed many darkly stained round isolectin B4‐positive phagocyte‐like microglial cells. Sparse TUNEL‐positive nuclei were found in the hippocampi of rats treated with Aβ(25–35) alone or together with TNFα, but not in the control brain sections or in brain sections of TNFα‐injected animals. The activity of caspase‐3 increased significantly in the ipsilateral hippocampus after the injection of Aβ(25–35). Surprisingly, administration of TNFα into the cerebral ventricles prevented this Aβ(25–35)‐induced increase in hippocampal caspase‐3 activity. The results are discussed from the perspective of dual (neuroprotective and neurodestructive) roles of TNF in the brain. © 2002 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/jnr.10469 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18652379</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18652379</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3909-c2ebda4190db07ea627641ac753d3b939009d06851bda75b7eb6044e793fb23c3</originalsourceid><addsrcrecordid>eNp1kE1v1DAQhi0EosvCgT-AfEL0YGrHX-sjqkopVAUKiKPl2BPqksSpnQj22l-Oyy5wQhppXmmeeQ8PQk8ZfckobY6ux1yDUOYeWjFqNBFS6PtoRbmiRFDWHKBHpVxTSo2R_CE6YI3QG8XMCt2edB34ueDU4XkZUsYj-JxKLLhzfk6ZuH66ctjDOGfXYxeGOMZS8xzTiOtcxWlK3g1TvQY3uG-A44jrva6weAi43WI3bPsUa4TZkQmmOQbALxpJuDx8jB50ri_wZL_X6Mvrk8_Hb8j5-9Oz41fnxHNDDfENtMEJZmhoqQanGq0Ec15LHnhrKkNNoGojWcW0bDW0igoB2vCubbjna_R81zvldLNAme0Qi4e-dyOkpVi2UbLhFV-jwx14J6Jk6OyU4-Dy1jJq74TbKtz-Fl7ZZ_vSpR0g_CP3hitwtAN-xB62_2-yby8u_1SS3UfVDD__frj83SrNtbRfL06t_Pjh8pN8xy3nvwAKi5oi</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18652379</pqid></control><display><type>article</type><title>Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25-35)</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Stepanichev, Mikhail Yu ; Zdobnova, Irina M. ; Yakovlev, Alexander A. ; Onufriev, Mikhail V. ; Lazareva, Natalia A. ; Zarubenko, Irina I. ; Gulyaeva, Natalia V.</creator><creatorcontrib>Stepanichev, Mikhail Yu ; Zdobnova, Irina M. ; Yakovlev, Alexander A. ; Onufriev, Mikhail V. ; Lazareva, Natalia A. ; Zarubenko, Irina I. ; Gulyaeva, Natalia V.</creatorcontrib><description>Male Wistar rats received unilateral intrahippocampal injections of 3 nmol (3.18 μg) aggregated Aβ(25–35), intracerebroventricular bilateral injections of 0.5 μg human recombinant TNFα or both (Aβ(25–35) + TNFα‐treated animals). Seven days after the surgery brain sections were stained with cresyl violet (Nissl), for fragmented DNA (TUNEL), glial fibrillar acidic protein (GFAP) and isolectin B4‐reactive microglia. In addition, caspase‐3 activity in brain regions was measured fluorometrically. The morphology of the hippocampus after the injection of Aβ(25–35) or both Aβ(25–35) and TNFα (but not TNFα alone) showed cell loss in the CA1 pyramidal cell layer. The extension of neuronal degeneration measured in the CA1 field was significantly larger in Aβ(25–35)‐treated groups compared to the contralateral hemisphere of both vehicle‐treated controls and animals injected with TNFα alone. TNFα augmented the Aβ(25–35)‐induced damage, significantly increasing the extension of degenerating area. Administration of Aβ(25–35) caused reactive gliosis in the ipsilateral hemisphere as demonstrated by upregulation of GFAP expression and the presence of hypertrophic astrocytes in the hippocampus. This effect was much more prominent in the hippocampi of rats treated with Aβ(25–35) + TNFα but absent after administration of TNFα alone. In both Aβ(25–35)‐treated groups, the damaged area of the hippocampal CA1 field and lateral band of dentate gyrus displayed many darkly stained round isolectin B4‐positive phagocyte‐like microglial cells. Sparse TUNEL‐positive nuclei were found in the hippocampi of rats treated with Aβ(25–35) alone or together with TNFα, but not in the control brain sections or in brain sections of TNFα‐injected animals. The activity of caspase‐3 increased significantly in the ipsilateral hippocampus after the injection of Aβ(25–35). Surprisingly, administration of TNFα into the cerebral ventricles prevented this Aβ(25–35)‐induced increase in hippocampal caspase‐3 activity. The results are discussed from the perspective of dual (neuroprotective and neurodestructive) roles of TNF in the brain. © 2002 Wiley‐Liss, Inc.</description><identifier>ISSN: 0360-4012</identifier><identifier>EISSN: 1097-4547</identifier><identifier>DOI: 10.1002/jnr.10469</identifier><identifier>PMID: 12478619</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Amyloid beta-Peptides - physiology ; Amyloid beta-Peptides - toxicity ; amyloid-β peptide (25-35) ; Animals ; Astrocytes ; astroglia ; Carrier Proteins - drug effects ; Carrier Proteins - metabolism ; CASP8 and FADD-Like Apoptosis Regulating Protein ; Cell Death - drug effects ; Cerebral Cortex - drug effects ; Cerebral Cortex - pathology ; Disease Models, Animal ; Drug Interactions ; Functional Laterality ; Glial Fibrillary Acidic Protein - drug effects ; Glial Fibrillary Acidic Protein - metabolism ; Gliosis - chemically induced ; Gliosis - prevention & control ; hippocampus ; Hippocampus - injuries ; Hippocampus - pathology ; Immunohistochemistry ; In Situ Nick-End Labeling ; Injections, Intraventricular ; Intracellular Signaling Peptides and Proteins ; Lectins ; Male ; microglia ; Microglia - metabolism ; Nerve Degeneration ; neurodegeneration ; Peptide Fragments - physiology ; Peptide Fragments - toxicity ; Random Allocation ; Rats ; Rats, Wistar ; Recombinant Fusion Proteins - therapeutic use ; tumor necrosis factor α ; Tumor Necrosis Factor-alpha - therapeutic use</subject><ispartof>Journal of neuroscience research, 2003-01, Vol.71 (1), p.110-120</ispartof><rights>Copyright © 2002 Wiley‐Liss, Inc.</rights><rights>Copyright 2002 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3909-c2ebda4190db07ea627641ac753d3b939009d06851bda75b7eb6044e793fb23c3</citedby><cites>FETCH-LOGICAL-c3909-c2ebda4190db07ea627641ac753d3b939009d06851bda75b7eb6044e793fb23c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjnr.10469$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjnr.10469$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12478619$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stepanichev, Mikhail Yu</creatorcontrib><creatorcontrib>Zdobnova, Irina M.</creatorcontrib><creatorcontrib>Yakovlev, Alexander A.</creatorcontrib><creatorcontrib>Onufriev, Mikhail V.</creatorcontrib><creatorcontrib>Lazareva, Natalia A.</creatorcontrib><creatorcontrib>Zarubenko, Irina I.</creatorcontrib><creatorcontrib>Gulyaeva, Natalia V.</creatorcontrib><title>Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25-35)</title><title>Journal of neuroscience research</title><addtitle>J. Neurosci. Res</addtitle><description>Male Wistar rats received unilateral intrahippocampal injections of 3 nmol (3.18 μg) aggregated Aβ(25–35), intracerebroventricular bilateral injections of 0.5 μg human recombinant TNFα or both (Aβ(25–35) + TNFα‐treated animals). Seven days after the surgery brain sections were stained with cresyl violet (Nissl), for fragmented DNA (TUNEL), glial fibrillar acidic protein (GFAP) and isolectin B4‐reactive microglia. In addition, caspase‐3 activity in brain regions was measured fluorometrically. The morphology of the hippocampus after the injection of Aβ(25–35) or both Aβ(25–35) and TNFα (but not TNFα alone) showed cell loss in the CA1 pyramidal cell layer. The extension of neuronal degeneration measured in the CA1 field was significantly larger in Aβ(25–35)‐treated groups compared to the contralateral hemisphere of both vehicle‐treated controls and animals injected with TNFα alone. TNFα augmented the Aβ(25–35)‐induced damage, significantly increasing the extension of degenerating area. Administration of Aβ(25–35) caused reactive gliosis in the ipsilateral hemisphere as demonstrated by upregulation of GFAP expression and the presence of hypertrophic astrocytes in the hippocampus. This effect was much more prominent in the hippocampi of rats treated with Aβ(25–35) + TNFα but absent after administration of TNFα alone. In both Aβ(25–35)‐treated groups, the damaged area of the hippocampal CA1 field and lateral band of dentate gyrus displayed many darkly stained round isolectin B4‐positive phagocyte‐like microglial cells. Sparse TUNEL‐positive nuclei were found in the hippocampi of rats treated with Aβ(25–35) alone or together with TNFα, but not in the control brain sections or in brain sections of TNFα‐injected animals. The activity of caspase‐3 increased significantly in the ipsilateral hippocampus after the injection of Aβ(25–35). Surprisingly, administration of TNFα into the cerebral ventricles prevented this Aβ(25–35)‐induced increase in hippocampal caspase‐3 activity. The results are discussed from the perspective of dual (neuroprotective and neurodestructive) roles of TNF in the brain. © 2002 Wiley‐Liss, Inc.</description><subject>Amyloid beta-Peptides - physiology</subject><subject>Amyloid beta-Peptides - toxicity</subject><subject>amyloid-β peptide (25-35)</subject><subject>Animals</subject><subject>Astrocytes</subject><subject>astroglia</subject><subject>Carrier Proteins - drug effects</subject><subject>Carrier Proteins - metabolism</subject><subject>CASP8 and FADD-Like Apoptosis Regulating Protein</subject><subject>Cell Death - drug effects</subject><subject>Cerebral Cortex - drug effects</subject><subject>Cerebral Cortex - pathology</subject><subject>Disease Models, Animal</subject><subject>Drug Interactions</subject><subject>Functional Laterality</subject><subject>Glial Fibrillary Acidic Protein - drug effects</subject><subject>Glial Fibrillary Acidic Protein - metabolism</subject><subject>Gliosis - chemically induced</subject><subject>Gliosis - prevention & control</subject><subject>hippocampus</subject><subject>Hippocampus - injuries</subject><subject>Hippocampus - pathology</subject><subject>Immunohistochemistry</subject><subject>In Situ Nick-End Labeling</subject><subject>Injections, Intraventricular</subject><subject>Intracellular Signaling Peptides and Proteins</subject><subject>Lectins</subject><subject>Male</subject><subject>microglia</subject><subject>Microglia - metabolism</subject><subject>Nerve Degeneration</subject><subject>neurodegeneration</subject><subject>Peptide Fragments - physiology</subject><subject>Peptide Fragments - toxicity</subject><subject>Random Allocation</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Recombinant Fusion Proteins - therapeutic use</subject><subject>tumor necrosis factor α</subject><subject>Tumor Necrosis Factor-alpha - therapeutic use</subject><issn>0360-4012</issn><issn>1097-4547</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1v1DAQhi0EosvCgT-AfEL0YGrHX-sjqkopVAUKiKPl2BPqksSpnQj22l-Oyy5wQhppXmmeeQ8PQk8ZfckobY6ux1yDUOYeWjFqNBFS6PtoRbmiRFDWHKBHpVxTSo2R_CE6YI3QG8XMCt2edB34ueDU4XkZUsYj-JxKLLhzfk6ZuH66ctjDOGfXYxeGOMZS8xzTiOtcxWlK3g1TvQY3uG-A44jrva6weAi43WI3bPsUa4TZkQmmOQbALxpJuDx8jB50ri_wZL_X6Mvrk8_Hb8j5-9Oz41fnxHNDDfENtMEJZmhoqQanGq0Ec15LHnhrKkNNoGojWcW0bDW0igoB2vCubbjna_R81zvldLNAme0Qi4e-dyOkpVi2UbLhFV-jwx14J6Jk6OyU4-Dy1jJq74TbKtz-Fl7ZZ_vSpR0g_CP3hitwtAN-xB62_2-yby8u_1SS3UfVDD__frj83SrNtbRfL06t_Pjh8pN8xy3nvwAKi5oi</recordid><startdate>20030101</startdate><enddate>20030101</enddate><creator>Stepanichev, Mikhail Yu</creator><creator>Zdobnova, Irina M.</creator><creator>Yakovlev, Alexander A.</creator><creator>Onufriev, Mikhail V.</creator><creator>Lazareva, Natalia A.</creator><creator>Zarubenko, Irina I.</creator><creator>Gulyaeva, Natalia V.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>20030101</creationdate><title>Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25-35)</title><author>Stepanichev, Mikhail Yu ; Zdobnova, Irina M. ; Yakovlev, Alexander A. ; Onufriev, Mikhail V. ; Lazareva, Natalia A. ; Zarubenko, Irina I. ; Gulyaeva, Natalia V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3909-c2ebda4190db07ea627641ac753d3b939009d06851bda75b7eb6044e793fb23c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Amyloid beta-Peptides - physiology</topic><topic>Amyloid beta-Peptides - toxicity</topic><topic>amyloid-β peptide (25-35)</topic><topic>Animals</topic><topic>Astrocytes</topic><topic>astroglia</topic><topic>Carrier Proteins - drug effects</topic><topic>Carrier Proteins - metabolism</topic><topic>CASP8 and FADD-Like Apoptosis Regulating Protein</topic><topic>Cell Death - drug effects</topic><topic>Cerebral Cortex - drug effects</topic><topic>Cerebral Cortex - pathology</topic><topic>Disease Models, Animal</topic><topic>Drug Interactions</topic><topic>Functional Laterality</topic><topic>Glial Fibrillary Acidic Protein - drug effects</topic><topic>Glial Fibrillary Acidic Protein - metabolism</topic><topic>Gliosis - chemically induced</topic><topic>Gliosis - prevention & control</topic><topic>hippocampus</topic><topic>Hippocampus - injuries</topic><topic>Hippocampus - pathology</topic><topic>Immunohistochemistry</topic><topic>In Situ Nick-End Labeling</topic><topic>Injections, Intraventricular</topic><topic>Intracellular Signaling Peptides and Proteins</topic><topic>Lectins</topic><topic>Male</topic><topic>microglia</topic><topic>Microglia - metabolism</topic><topic>Nerve Degeneration</topic><topic>neurodegeneration</topic><topic>Peptide Fragments - physiology</topic><topic>Peptide Fragments - toxicity</topic><topic>Random Allocation</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Recombinant Fusion Proteins - therapeutic use</topic><topic>tumor necrosis factor α</topic><topic>Tumor Necrosis Factor-alpha - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stepanichev, Mikhail Yu</creatorcontrib><creatorcontrib>Zdobnova, Irina M.</creatorcontrib><creatorcontrib>Yakovlev, Alexander A.</creatorcontrib><creatorcontrib>Onufriev, Mikhail V.</creatorcontrib><creatorcontrib>Lazareva, Natalia A.</creatorcontrib><creatorcontrib>Zarubenko, Irina I.</creatorcontrib><creatorcontrib>Gulyaeva, Natalia V.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Journal of neuroscience research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stepanichev, Mikhail Yu</au><au>Zdobnova, Irina M.</au><au>Yakovlev, Alexander A.</au><au>Onufriev, Mikhail V.</au><au>Lazareva, Natalia A.</au><au>Zarubenko, Irina I.</au><au>Gulyaeva, Natalia V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25-35)</atitle><jtitle>Journal of neuroscience research</jtitle><addtitle>J. Neurosci. Res</addtitle><date>2003-01-01</date><risdate>2003</risdate><volume>71</volume><issue>1</issue><spage>110</spage><epage>120</epage><pages>110-120</pages><issn>0360-4012</issn><eissn>1097-4547</eissn><abstract>Male Wistar rats received unilateral intrahippocampal injections of 3 nmol (3.18 μg) aggregated Aβ(25–35), intracerebroventricular bilateral injections of 0.5 μg human recombinant TNFα or both (Aβ(25–35) + TNFα‐treated animals). Seven days after the surgery brain sections were stained with cresyl violet (Nissl), for fragmented DNA (TUNEL), glial fibrillar acidic protein (GFAP) and isolectin B4‐reactive microglia. In addition, caspase‐3 activity in brain regions was measured fluorometrically. The morphology of the hippocampus after the injection of Aβ(25–35) or both Aβ(25–35) and TNFα (but not TNFα alone) showed cell loss in the CA1 pyramidal cell layer. The extension of neuronal degeneration measured in the CA1 field was significantly larger in Aβ(25–35)‐treated groups compared to the contralateral hemisphere of both vehicle‐treated controls and animals injected with TNFα alone. TNFα augmented the Aβ(25–35)‐induced damage, significantly increasing the extension of degenerating area. Administration of Aβ(25–35) caused reactive gliosis in the ipsilateral hemisphere as demonstrated by upregulation of GFAP expression and the presence of hypertrophic astrocytes in the hippocampus. This effect was much more prominent in the hippocampi of rats treated with Aβ(25–35) + TNFα but absent after administration of TNFα alone. In both Aβ(25–35)‐treated groups, the damaged area of the hippocampal CA1 field and lateral band of dentate gyrus displayed many darkly stained round isolectin B4‐positive phagocyte‐like microglial cells. Sparse TUNEL‐positive nuclei were found in the hippocampi of rats treated with Aβ(25–35) alone or together with TNFα, but not in the control brain sections or in brain sections of TNFα‐injected animals. The activity of caspase‐3 increased significantly in the ipsilateral hippocampus after the injection of Aβ(25–35). Surprisingly, administration of TNFα into the cerebral ventricles prevented this Aβ(25–35)‐induced increase in hippocampal caspase‐3 activity. The results are discussed from the perspective of dual (neuroprotective and neurodestructive) roles of TNF in the brain. © 2002 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>12478619</pmid><doi>10.1002/jnr.10469</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0360-4012 |
ispartof | Journal of neuroscience research, 2003-01, Vol.71 (1), p.110-120 |
issn | 0360-4012 1097-4547 |
language | eng |
recordid | cdi_proquest_miscellaneous_18652379 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Amyloid beta-Peptides - physiology Amyloid beta-Peptides - toxicity amyloid-β peptide (25-35) Animals Astrocytes astroglia Carrier Proteins - drug effects Carrier Proteins - metabolism CASP8 and FADD-Like Apoptosis Regulating Protein Cell Death - drug effects Cerebral Cortex - drug effects Cerebral Cortex - pathology Disease Models, Animal Drug Interactions Functional Laterality Glial Fibrillary Acidic Protein - drug effects Glial Fibrillary Acidic Protein - metabolism Gliosis - chemically induced Gliosis - prevention & control hippocampus Hippocampus - injuries Hippocampus - pathology Immunohistochemistry In Situ Nick-End Labeling Injections, Intraventricular Intracellular Signaling Peptides and Proteins Lectins Male microglia Microglia - metabolism Nerve Degeneration neurodegeneration Peptide Fragments - physiology Peptide Fragments - toxicity Random Allocation Rats Rats, Wistar Recombinant Fusion Proteins - therapeutic use tumor necrosis factor α Tumor Necrosis Factor-alpha - therapeutic use |
title | Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25-35) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T23%3A41%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20tumor%20necrosis%20factor-alpha%20central%20administration%20on%20hippocampal%20damage%20in%20rat%20induced%20by%20amyloid%20beta-peptide%20(25-35)&rft.jtitle=Journal%20of%20neuroscience%20research&rft.au=Stepanichev,%20Mikhail%20Yu&rft.date=2003-01-01&rft.volume=71&rft.issue=1&rft.spage=110&rft.epage=120&rft.pages=110-120&rft.issn=0360-4012&rft.eissn=1097-4547&rft_id=info:doi/10.1002/jnr.10469&rft_dat=%3Cproquest_cross%3E18652379%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18652379&rft_id=info:pmid/12478619&rfr_iscdi=true |